126 related articles for article (PubMed ID: 2392594)
21. [Skin manifestations of Lyme borreliosis].
Nammous AH; Zubacki D; Dobrzycki I
Przegl Lek; 2006; 63(4):227-30. PubMed ID: 17080746
[TBL] [Abstract][Full Text] [Related]
22. [Negativity of Borrelia burgdorferi serology in scleroderma en plaques].
Lecerf V; Bagot M; Dournon E; Cosnes A; Touraine R; Revuz J
Ann Dermatol Venereol; 1989; 116(8):539-42. PubMed ID: 2688515
[TBL] [Abstract][Full Text] [Related]
23. The expanding spectrum of cutaneous borreliosis.
Eisendle K; Zelger B
G Ital Dermatol Venereol; 2009 Apr; 144(2):157-71. PubMed ID: 19357623
[TBL] [Abstract][Full Text] [Related]
24. Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes.
Asbrink E
Acta Derm Venereol Suppl (Stockh); 1985; 118():1-63. PubMed ID: 3901647
[TBL] [Abstract][Full Text] [Related]
25. No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment.
Muellegger RR; Zoechling N; Soyer HP; Hoedl S; Wienecke R; Volkenandt M; Kerl H
Arch Dermatol; 1995 Jun; 131(6):678-82. PubMed ID: 7778919
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous manifestations of Lyme borreliosis.
Berger BW
Rheum Dis Clin North Am; 1989 Nov; 15(4):627-34. PubMed ID: 2685922
[TBL] [Abstract][Full Text] [Related]
27. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
Fürst B; Glatz M; Kerl H; Müllegger RR
Clin Exp Dermatol; 2006 Jul; 31(4):509-14. PubMed ID: 16716151
[TBL] [Abstract][Full Text] [Related]
28. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?
Logar M; Lotric-Furlan S; Maraspin V; Cimperman J; Jurca T; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):945-50. PubMed ID: 10666806
[TBL] [Abstract][Full Text] [Related]
29. [Localized scleroderma (morphea) and septic arthritis. Clinical manifestations of Lyme borreliosis seen in El Ferrol].
Maestre JR; Almagro M; Martínez P; de Casas R; Quesada R; Egido J
Enferm Infecc Microbiol Clin; 1991; 9(7):394-8. PubMed ID: 1799607
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to the Borrelia burgdorferi flagellum in patients with scleroderma, granuloma annulare and porphyria cutanea tarda.
Halkier-Sørensen L; Kragballe K; Hansen K
Acta Derm Venereol; 1989; 69(2):116-9. PubMed ID: 2564227
[TBL] [Abstract][Full Text] [Related]
31. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases.
Prinz JC; Kutasi Z; Weisenseel P; Pótó L; Battyáni Z; Ruzicka T
J Am Acad Dermatol; 2009 Feb; 60(2):248-55. PubMed ID: 19022534
[TBL] [Abstract][Full Text] [Related]
32. [Skin manifestations of Lyme borreliosis in patients at the 1st Dermato-venereologic Clinic of Comenius University Medical School in Bratislava 1996-1998].
Svecová D; Buchvald J; Oprsalová K; Dolezalová A
Epidemiol Mikrobiol Imunol; 2000 Aug; 49(3):115-22. PubMed ID: 11040493
[TBL] [Abstract][Full Text] [Related]
33. Absence of Borrelia burgdorferi antibodies in the sera of Venezuelan patients with localized scleroderma (morphea).
Espinoza-León F; Hassanhi-Hassanhi M; Arocha-Sandoval F; Urbina-López M
Invest Clin; 2006 Sep; 47(3):283-8. PubMed ID: 17672287
[TBL] [Abstract][Full Text] [Related]
34. [In vivo and in vitro detection of borrelia infection in morphea-like skin changes with negative Borrelia serology].
Schempp C; Bocklage H; Owsianowski M; Lange R; Orfanos CE; Gollnick H
Hautarzt; 1993 Jan; 44(1):14-8. PubMed ID: 8436502
[TBL] [Abstract][Full Text] [Related]
35. [Clinical picture of Lyme boreliosis].
Flisiak R; Prokopowicz D
Wiad Parazytol; 1999; 45(2):143-9. PubMed ID: 16886455
[TBL] [Abstract][Full Text] [Related]
36. Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia.
Golubić D; Rijpkema S; Tkalec-Makovec N; Ruzić E
Acta Med Croatica; 1998; 52(1):7-13. PubMed ID: 9599811
[TBL] [Abstract][Full Text] [Related]
37. Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma.
Breier P; Klade H; Stanek G; Poitschek C; Kirnbauer R; Dorda W; Aberer E
Br J Dermatol; 1996 Feb; 134(2):285-91. PubMed ID: 8746343
[TBL] [Abstract][Full Text] [Related]
38. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus.
Eisendle K; Grabner T; Kutzner H; Zelger B
Arch Dermatol; 2008 May; 144(5):591-8. PubMed ID: 18490585
[TBL] [Abstract][Full Text] [Related]
39. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in urine specimens of patients with erythema migrans lesions.
Mercier G; Burckel A; Lucotte G
Mol Cell Probes; 1997 Apr; 11(2):89-94. PubMed ID: 9160322
[TBL] [Abstract][Full Text] [Related]
40. [Antibodies against Borrelia afzelli in patients with an early stage of Lyme disease].
Flisiak I; Chodynicka B
Wiad Lek; 2001; 54(1-2):19-25. PubMed ID: 11344697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
